Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
Aditi Sinha, for the Indian HUS Registry, Caroline Blanc(Université Claude Bernard Lyon 1), Vineeta Bal(Indian Institute of Science Education and Research Pune), Himanshi Saini(All India Institute of Medical Sciences), Shambhuprasad Kotresh Togarsimalemath(Inserm), M. Vijayakumar(Dr. Mehta's Children's Hospital), Amit Kumar Dinda(All India Institute of Medical Sciences), Sanjeev Gulati(Fortis Hospital), Divya Bhatia(Hypertension Institute), Maud Salmona(Inserm), Ashima Gulati(All India Institute of Medical Sciences), Anna George(Hoshi University), Rajiv Sinha(Institute of Child Health), Arvind Bagga(All India Institute of Medical Sciences), Indira Agarwal(Christian Medical College, Vellore), Marie‐Agnès Dragon‐Durey(Centre de Recherche des Cordeliers), Pankaj Hari(Indian Council of Medical Research), Uma Ali(Bai Jerbai Wadia Hospital for Children), Geetika Singh(All India Institute of Medical Sciences), Manish Kumar(Sterling Hospitals), Aarti Gupta(All India Institute of Medical Sciences), Savita Saini(All India Institute of Medical Sciences), Sidharth Kumar Sethi(Medanta The Medicity), Kanav Anand(Sir Ganga Ram Hospital), Satyajit Rath(National Institute of Immunology), Alpana Ohri(Bai Jerbai Wadia Hospital for Children), Bahadur Singh Gurjar(National Institute of Immunology)
Cited by 216
Related Papers
Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study
|The Lancet Child & Adolescent Health|2017|722
Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome
|Journal of the American Society of Nephrology|2004|415
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome
|Clinical Journal of the American Society of Nephrology|2010|203